vs

Side-by-side financial comparison of Arch Capital Group (ACGL) and Labcorp (LH). Click either name above to swap in a different company.

Arch Capital Group is the larger business by last-quarter revenue ($4.5B vs $3.5B, roughly 1.3× Labcorp). Arch Capital Group runs the higher net margin — 23.2% vs 4.7%, a 18.5% gap on every dollar of revenue. On growth, Labcorp posted the faster year-over-year revenue change (5.7% vs -3.3%). Over the past eight quarters, Labcorp's revenue compounded faster (4.5% CAGR vs 3.4%).

Arch Capital Group Ltd. is a Bermuda exempted public company which writes insurance, reinsurance and mortgage insurance on a worldwide basis, with a focus on specialty lines, the segment of the insurance industry where the more difficult and unusual risks are written. The company is headquartered in Bermuda and operates globally in 60 offices in North America, Europe, Asia and Australia.

Labcorp is a leading global life sciences and diagnostic testing firm that offers comprehensive clinical laboratory services, drug development support, and medical testing solutions for healthcare providers, pharmaceutical companies, and individual patients. It uses advanced scientific expertise and innovative technologies to deliver accurate, actionable health insights that support clinical decisions, accelerate new treatment development, and improve patient health outcomes globally.

ACGL vs LH — Head-to-Head

Bigger by revenue
ACGL
ACGL
1.3× larger
ACGL
$4.5B
$3.5B
LH
Growing faster (revenue YoY)
LH
LH
+9.0% gap
LH
5.7%
-3.3%
ACGL
Higher net margin
ACGL
ACGL
18.5% more per $
ACGL
23.2%
4.7%
LH
Faster 2-yr revenue CAGR
LH
LH
Annualised
LH
4.5%
3.4%
ACGL

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ACGL
ACGL
LH
LH
Revenue
$4.5B
$3.5B
Net Profit
$1.0B
$164.7M
Gross Margin
28.2%
Operating Margin
7.6%
Net Margin
23.2%
4.7%
Revenue YoY
-3.3%
5.7%
Net Profit YoY
82.4%
14.9%
EPS (diluted)
$2.88
$1.98

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACGL
ACGL
LH
LH
Q1 26
$4.5B
$3.5B
Q4 25
$4.9B
$3.5B
Q3 25
$5.1B
$3.6B
Q2 25
$5.2B
$3.5B
Q1 25
$4.7B
$3.3B
Q4 24
$4.5B
$3.3B
Q3 24
$4.7B
$3.3B
Q2 24
$4.2B
$3.2B
Net Profit
ACGL
ACGL
LH
LH
Q1 26
$1.0B
$164.7M
Q4 25
$1.2B
$164.7M
Q3 25
$1.4B
$261.1M
Q2 25
$1.2B
$237.9M
Q1 25
$574.0M
$212.8M
Q4 24
$935.0M
$143.4M
Q3 24
$988.0M
$169.3M
Q2 24
$1.3B
$205.3M
Gross Margin
ACGL
ACGL
LH
LH
Q1 26
28.2%
Q4 25
28.2%
Q3 25
28.8%
Q2 25
29.7%
Q1 25
28.3%
Q4 24
26.9%
Q3 24
27.6%
Q2 24
28.8%
Operating Margin
ACGL
ACGL
LH
LH
Q1 26
7.6%
Q4 25
7.6%
Q3 25
11.1%
Q2 25
11.2%
Q1 25
9.7%
Q4 24
6.5%
Q3 24
7.7%
Q2 24
9.2%
Net Margin
ACGL
ACGL
LH
LH
Q1 26
23.2%
4.7%
Q4 25
25.1%
4.7%
Q3 25
26.4%
7.3%
Q2 25
23.7%
6.7%
Q1 25
12.3%
6.4%
Q4 24
20.6%
4.3%
Q3 24
20.9%
5.2%
Q2 24
30.0%
6.4%
EPS (diluted)
ACGL
ACGL
LH
LH
Q1 26
$2.88
$1.98
Q4 25
$3.33
$1.98
Q3 25
$3.56
$3.12
Q2 25
$3.23
$2.84
Q1 25
$1.48
$2.52
Q4 24
$2.41
$1.72
Q3 24
$2.56
$2.00
Q2 24
$3.30
$2.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACGL
ACGL
LH
LH
Cash + ST InvestmentsLiquidity on hand
$24.0M
$532.3M
Total DebtLower is stronger
$5.1B
Stockholders' EquityBook value
$24.2B
$8.6B
Total Assets
$81.4B
$18.4B
Debt / EquityLower = less leverage
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACGL
ACGL
LH
LH
Q1 26
$24.0M
$532.3M
Q4 25
$993.0M
$532.3M
Q3 25
$1.1B
$598.1M
Q2 25
$983.0M
$647.3M
Q1 25
$1.2B
$369.4M
Q4 24
$979.0M
$1.5B
Q3 24
$1.0B
$1.5B
Q2 24
$1.0B
$265.1M
Total Debt
ACGL
ACGL
LH
LH
Q1 26
$5.1B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
ACGL
ACGL
LH
LH
Q1 26
$24.2B
$8.6B
Q4 25
$24.2B
$8.6B
Q3 25
$23.7B
$8.7B
Q2 25
$23.0B
$8.5B
Q1 25
$21.5B
$8.3B
Q4 24
$20.8B
$8.1B
Q3 24
$22.3B
$8.2B
Q2 24
$20.7B
$8.0B
Total Assets
ACGL
ACGL
LH
LH
Q1 26
$81.4B
$18.4B
Q4 25
$79.2B
$18.4B
Q3 25
$79.2B
$18.3B
Q2 25
$78.8B
$18.1B
Q1 25
$75.2B
$17.6B
Q4 24
$70.9B
$18.4B
Q3 24
$73.7B
$18.6B
Q2 24
$65.5B
$16.7B
Debt / Equity
ACGL
ACGL
LH
LH
Q1 26
0.59×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACGL
ACGL
LH
LH
Operating Cash FlowLast quarter
$1.2B
$614.2M
Free Cash FlowOCF − Capex
$490.3M
FCF MarginFCF / Revenue
13.9%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
1.13×
3.73×
TTM Free Cash FlowTrailing 4 quarters
$1.8B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACGL
ACGL
LH
LH
Q1 26
$1.2B
$614.2M
Q4 25
$1.4B
$614.2M
Q3 25
$2.2B
$387.2M
Q2 25
$1.1B
$620.6M
Q1 25
$1.5B
$18.5M
Q4 24
$1.6B
$777.2M
Q3 24
$2.0B
$277.3M
Q2 24
$1.5B
$561.1M
Free Cash Flow
ACGL
ACGL
LH
LH
Q1 26
$490.3M
Q4 25
$1.4B
$490.3M
Q3 25
$2.2B
$280.5M
Q2 25
$1.1B
$542.7M
Q1 25
$1.4B
$-107.5M
Q4 24
$1.6B
$665.1M
Q3 24
$2.0B
$161.5M
Q2 24
$1.5B
$432.9M
FCF Margin
ACGL
ACGL
LH
LH
Q1 26
13.9%
Q4 25
28.2%
13.9%
Q3 25
42.6%
7.9%
Q2 25
21.3%
15.4%
Q1 25
31.0%
-3.2%
Q4 24
34.3%
20.0%
Q3 24
42.5%
4.9%
Q2 24
35.6%
13.4%
Capex Intensity
ACGL
ACGL
LH
LH
Q1 26
3.5%
Q4 25
0.2%
3.5%
Q3 25
0.2%
3.0%
Q2 25
0.2%
2.2%
Q1 25
0.2%
3.8%
Q4 24
0.3%
3.4%
Q3 24
0.3%
3.5%
Q2 24
0.3%
4.0%
Cash Conversion
ACGL
ACGL
LH
LH
Q1 26
1.13×
3.73×
Q4 25
1.13×
3.73×
Q3 25
1.62×
1.48×
Q2 25
0.91×
2.61×
Q1 25
2.54×
0.09×
Q4 24
1.68×
5.42×
Q3 24
2.04×
1.64×
Q2 24
1.20×
2.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACGL
ACGL

Segment breakdown not available.

LH
LH

Revenues$2.7B78%
Other$787.3M22%

Related Comparisons